IDH1 and central nervous system cancer: IDH1/2 mutations were not only found in gliomas but also in other tumors such as acute myeloid leukemia (AML), myelodysplastic syndrome, myeloproliferative neoplasm, cholangiosarcoma, enchondroma, chondrosarcoma, and other solid cancers [5,6].